How to Get Vitrakvi (larotrectinib) Covered by Cigna in Texas: Complete Prior Authorization and Appeals Guide
Answer Box: Getting Vitrakvi Covered by Cigna in Texas
Eligibility: Vitrakvi (larotrectinib) requires prior authorization from Cigna for patients with NTRK gene fusion-positive solid tumors that are metastatic or unresectable.
Fastest path to approval: Have your oncologist submit a prior authorization request through CignaforHCP.com with complete NTRK fusion testing